Cerevel Therapeutics Holdings, Inc. Operating Income 2021-2024 | CERE
Cerevel Therapeutics Holdings, Inc. operating income from 2021 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Cerevel Therapeutics Holdings, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-447 |
| 2022 | $-368 |
| 2021 | $-220 |
| 2020 | $-149 |
| 2019 | $-83 |
| 2018 | $-121 |
| Cerevel Therapeutics Holdings, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-143 |
| 2023-12-31 | $-140 |
| 2023-09-30 | $-111 |
| 2023-06-30 | $-97 |
| 2023-03-31 | $-100 |
| 2022-12-31 | $-107 |
| 2022-09-30 | $-95 |
| 2022-06-30 | $-93 |
| 2022-03-31 | $-73 |
| 2021-12-31 | $-64 |
| 2021-09-30 | $-55 |
| 2021-06-30 | $-51 |
| 2021-03-31 | $-51 |
| 2020-12-31 | $-42 |
| 2020-09-30 | $-34 |
| 2020-06-30 | $-35 |
| 2020-03-31 | $-38 |
